Rchr
J-GLOBAL ID：200901042659237701
Update date: Nov. 20, 2024
Irie Keiichi
イリエ ケイイチ | Irie Keiichi
Affiliation and department：
Research field (1)：
Pharmacology
Research theme for competitive and other funds (1)：
- 2024 - 2027 The exploration of new therapeutic agents for frontotemporal lobar degeneration focusing on read-through activity.
Papers (79)：
-
Takafumi Nakano, Keiichi Irie, Koichi Matsuo, Kenichi Mishima, Yoshihiko Nakamura. Molecular and cellular mechanisms of mitochondria transfer in models of central nervous system disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2024. 271678X241300223
-
Mayuka Morimoto, Takafumi Nakano, Saki Egashira, Keiichi Irie, Kiyoshi Matsuyama, Momoka Wada, Yoshihiko Nakamura, Yutaka Shigemori, Hiroyasu Ishikura, Yuta Yamashita, et al. Haptoglobin Regulates Macrophage/Microglia-Induced Inflammation and Prevents Ischemic Brain Damage Via Binding to HMGB1. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022. 11. 6
-
Kazunori Sano, Yasushi Iwasaki, Yuta Yamashita, Keiichi Irie, Masato Hosokawa, Katsuya Satoh, Kenichi Mishima. Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2. Acta neuropathologica communications. 2021. 9. 1. 182-182
-
Takafumi Nakano, Yoshihiko Nakamura, Keiichi Irie, Shinobu Okano, Mayuka Morimoto, Yuta Yamashita, Tomohiro Kozako, Toshinobu Hayashi, Shin-Ichiro Honda, Koichi Matsuo, et al. Antithrombin gamma attenuates macrophage/microglial activation and brain damage after transient focal cerebral ischemia in mice. Life Sci. 2020. 252. 117665-117665
-
Masathoshi Honjo, Okuraha Yasuhide, Masayoshi Yamada, Sei Higuchi, Kenji Mishima, Tanjina Sharmin, Taku Michael Aida, Takafumi Kato, Makoto Misumi, Tadashi Suetsugu, et al. Characterization and pharmacokinetics evaluation of microcomposite particles of alpha lipoic acid/hydrogenated colza oil obtained in supercritical carbon dioxide. Pharm Dev Technol. 2020. 25. 3. 359-365
ｍore...
MISC (20)：
-
江頭早紀, 真崎有裕子, 向井梨恵, 中野貴文, 中野貴文, 細川雅人, 亀谷富由樹, 入江圭一, 佐藤朝光, 山下郁太, et al. Dynamics of plasma Serum Amyloid A (SAA) level following focal cerebral ischemia in mice. 日本薬学会年会要旨集(Web). 2023. 143rd
-
西上知佐, 中野貴文, 中野貴文, 水野寧子, 入江圭一, 山下郁太, 明瀬孝之, 高瀬友美, 藤岡政行, 佐藤朝光, et al. 脳虚血-再灌流障害モデルマウスを用いた脳浮腫に対する五苓散の効果. 和漢医薬学会学術大会要旨集. 2016. 33rd. 95-95
-
中野貴文, 入江圭一. 血小板凝集因子vWF切断酵素ADAMTS13とそのマルチドメインによる脳保護効果の解明. 福岡大学産学官連携研究機関加齢脳科学研究所 2013年度研究成果報告書:37-49、2014. 2014. p37-74
-
Masayoshi Tanaka, Keiichi Irie, Takafumi Nakano, Kaori Kubota, Shutaro Katsurabayashi, Kotaro Takasaki, Koujirou Futagami, Kenichi Mishima, Katsunori Iwasaki. Involvement of trombospondin 1 on cerebroprotective effect of ADAMTS13 in brain injury after transient focal cerebral ischemia. JOURNAL OF PHARMACOLOGICAL SCIENCES. 2014. 124. 148P-148P
-
末延竜哉, SHARMIN Tanjina, 佐藤朝光, 入江圭一, 細川雅人, 平松征洋, 上田紗織, 中島幸彦, 鹿志毛信広, 見明史雄, et al. ミルセンによるアジュバント効果とその作用機序. J Tradit Med. 2013. 30. Suppl. 95-95
ｍore...
Lectures and oral presentations (53)：
-
Long-term treatment with recombinant human soluble thrombomodulin improves ischemic brain damage via regulating systemic HMGB1 levels in mice
(Neuroscience 2018 2018)
-
脳虚血-再灌流障害モデルを用いた脳浮腫に対する五苓散の効果
(第33回和漢医薬学会学術大会 2016)
-
Effect of Δ9-Tetrahydrocannabinol and Methamphetamine on the drug-induced ultrasonic vocalizations in rats.
(日本薬学会第136年会 2016)
-
Dynamics of neurodegenerative disease,Amyotrophic-Lateral-Screlosis gene in oxaliplatin-induced peripheral neuropathy in rats.
(日本薬学会第136年会 2016)
-
がん化学療法に伴う末梢神経障害におけるCharcot-Marie-Tooth病原因遺伝子の関与
(日本臨床腫瘍薬学会学術大会2016 2016)
ｍore...
Education (1)：
- 1999 - 2003 Fukuoka University Graduate School, Division of Pharmaceutical Sciences Pharmaceutical Sciences
Professional career (1)：
Return to Previous Page
